King's College India Marks a Decade of Learning and Legacy with 10th Founder's Day Celebration

India, Sept. 7 -- HT Syndication Rohtak (Haryana) [India], September 7: King's College India, Rohtak, an international school, marked a significant milestone with its 10th Founder's Day, celebrating ... Read More

Inaugural SuperNova Football Championship concludes in Bengaluru, celebrates girls' football

Bengaluru, Sept. 7 -- The inaugural SuperNova Football Championship (SNFC) concluded on Sunday at Depot18, Bengaluru, marking a strong start to Capri Sports' Nova Sports initiative. Over two days, sc... Read More

Emmy Awards 2026: Spider-Noir wins five awards days after cancellation, Rob Reiner bags posthumous win

India, Sept. 7 -- The Primetime Emmy Awards 2026 may still be a week away, but the award season has begun. Over the weekend, the Television Academy handed out early awards in technical and creative ca... Read More

Ranveer Singh sports Dhurandhar-style long hair, walks with Kalyani Priyadarshan in leaked video from Pralay set. Watch

India, Sept. 7 -- After impressing audiences with Dhurandhar and Dhurandhar: The Revenge, Ranveer Singh has moved on to his next project. The actor is currently shooting for his upcoming film Pralay, ... Read More

Rewriting the enterprise operating model: the real AI story

India, Sept. 7 -- Enterprises poured more than $250 billion into AI globally in 2025. Yet only one in four organizations says AI has a truly transformative impact. This gap isn't about the amount of m... Read More

Temba Bavuma to lead South Africa in ODI series against Australia

Johannesburg, Sept. 7 -- South Africa have announced a near full-strength squad for their upcoming home ODI series against Australia, with regular captain Temba Bavuma set to lead the side. The squad... Read More

Susan Sarandon reveals why she's losing major opportunitiesPublished on: September 7, 2026 10:06 AM

Pakistan, Sept. 7 -- Susan Sarandon says she is still losing major acting opportunities because of her public views. The Oscar winning actress talked about the issue during a press conference at the V... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event – MOVE-Lp(a)

Singapore, Sept. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvala... Read More

Singapore Clinical Trial: FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer

Singapore, Sept. 7 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More

Singapore Clinical Trial: A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum- Sensitive Ovarian Cancer (PSOC)

Singapore, Sept. 7 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ver... Read More

• ««
• «
• 255
• 256
• 257
• 258
• 259
• 260
• 261
• 262
• 263
• 264
• »
• »»